Court Rejects Motion To Declare Roche DNA Replication Technology Patents Unenforceable
A California U.S. District Court has refused to find Roche Diagnostics' portfolio of patents to its DNA replication technology unenforceable, dealing a setback to rival Promega in the decade-old battle over...To view the full article, register now.
Already a subscriber? Click here to view full article